Hagel C, Schwartz P, Laas R, Stavrou D
UNIV HAMBURG,DEPT NEUROSURG,D-20246 HAMBURG,GERMANY.
Int J Oncol. 1995 Jul;7(1):107-13. doi: 10.3892/ijo.7.1.107.
The proliferation indices of immunohistochemically detected bromodeoxyuridine, Ki-67 antigen (antibodies Ki-67 and MIB 1), and proliferating cell nuclear antigen were determined manually and with computer assisted morphometry in 38 gliomas, 29 meningeomas, 9 metastases, and 16 other tumors. Comparing the markers among one another the highest correlation coefficient was found for bromodeoxyuridine and MIB 1 (0.9). The proliferation indices of all markers correlated significantly with the tumor grading. The highest correlation coefficient for proliferation index and grading (0.7) was calculated for the MIB 1 index determined in one high power field (0.0153 mm(2)) in the tissue area with the highest proliferative activity. Concerning applicability and correlation with tumor dignity MIB 1 was superior to the other three antibodies investigated.
采用手动及计算机辅助形态测量法,测定了38例神经胶质瘤、29例脑膜瘤、9例转移瘤和16例其他肿瘤中免疫组化检测到的溴脱氧尿苷、Ki-67抗原(Ki-67和MIB 1抗体)及增殖细胞核抗原的增殖指数。相互比较这些标志物时,发现溴脱氧尿苷与MIB 1之间的相关系数最高(0.9)。所有标志物的增殖指数均与肿瘤分级显著相关。在增殖活性最高的组织区域,于一个高倍视野(0.0153平方毫米)中测定的MIB 1指数,其增殖指数与分级的相关系数最高(0.7)。就适用性及与肿瘤性质的相关性而言,MIB 1优于所研究的其他三种抗体。